Nutraceuticals under the spotlight

Article

Lutein, beta-carotene, zeaxanthin, astaxanthin, bilberry are eye health ingredients under the spotlight in a new European Health Ingredients Market report.

According to the study's authors, business analysts, Frost & Sullivan: “The rising prevalence of lifestyle-linked eye diseases has caused the global food ingredients market to leverage the consumer s need to protect their eyes through enhanced nutrition.

“The focus on eye health has become a primary concern in today's health conscious food industry. Eye health is a key component of a healthy life and the market for eye health ingredients witnessed growth in 2007, spurred by the incidence of eye-diseases such as glaucoma, age-related macular degeneration, cataracts, and childhood blindness. As a result of the scale of visual impairment problems, many consumers are making lifestyle changes, switching to nutrient-rich diets that will aid in protecting visual acuity, preventing cataract and blindness, and safeguarding their eyesight from harmful exposure to ultraviolet rays. Since 2007, the European market for eye health ingredients has been dominated by antioxidants. Key eye health ingredients in use in 2007 included lutein, beta-carotene and zeaxanthin.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.